SCHENA, Francesco Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.883
AS - Asia 2.384
EU - Europa 1.934
SA - Sud America 568
Continente sconosciuto - Info sul continente non disponibili 361
AF - Africa 103
OC - Oceania 6
AN - Antartide 1
Totale 11.240
Nazione #
US - Stati Uniti d'America 5.757
SG - Singapore 951
IT - Italia 582
CN - Cina 533
BR - Brasile 453
SE - Svezia 321
HK - Hong Kong 264
RU - Federazione Russa 240
DE - Germania 195
VN - Vietnam 172
FI - Finlandia 144
FR - Francia 123
GB - Regno Unito 117
BD - Bangladesh 108
IN - India 85
CA - Canada 61
UA - Ucraina 42
ID - Indonesia 36
BE - Belgio 35
AR - Argentina 34
TR - Turchia 33
MX - Messico 32
IQ - Iraq 30
JP - Giappone 26
NL - Olanda 26
ZA - Sudafrica 26
PL - Polonia 25
CI - Costa d'Avorio 24
EC - Ecuador 21
SA - Arabia Saudita 21
CO - Colombia 20
PH - Filippine 16
UZ - Uzbekistan 15
AT - Austria 13
MA - Marocco 12
PK - Pakistan 12
ES - Italia 11
LT - Lituania 11
CZ - Repubblica Ceca 10
IE - Irlanda 10
TN - Tunisia 10
VE - Venezuela 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
IL - Israele 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
PY - Paraguay 7
AU - Australia 6
BO - Bolivia 6
CL - Cile 6
EG - Egitto 6
JM - Giamaica 6
LB - Libano 6
CR - Costa Rica 5
ET - Etiopia 5
KW - Kuwait 5
TH - Thailandia 5
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PE - Perù 4
TT - Trinidad e Tobago 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
SI - Slovenia 2
SR - Suriname 2
SV - El Salvador 2
AL - Albania 1
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
DM - Dominica 1
Totale 10.868
Città #
Ashburn 649
Fairfield 565
Singapore 499
Chandler 407
San Jose 405
Woodbridge 328
Houston 263
Hong Kong 262
Nyköping 259
Ann Arbor 255
Cambridge 232
Seattle 216
Milan 206
Beijing 174
Wilmington 171
New York 138
Council Bluffs 128
Helsinki 104
Los Angeles 98
Dallas 79
Jacksonville 76
Dearborn 75
Lawrence 75
Roxbury 75
Lauterbourg 74
Nanjing 73
Munich 67
Santa Clara 63
Bari 59
Ho Chi Minh City 59
Rome 56
Des Moines 46
São Paulo 46
Inglewood 39
Brooklyn 36
Hanoi 36
Columbus 35
Phoenix 35
Brussels 34
Buffalo 33
San Diego 30
Chicago 27
Abidjan 24
Boardman 24
Warsaw 24
Montreal 23
Jakarta 22
Shenyang 21
Tokyo 21
Atlanta 20
Frankfurt am Main 20
Orem 19
Toronto 19
Turku 18
Amsterdam 17
London 17
Stockholm 17
Dong Ket 16
Falkenstein 16
Nanchang 16
Hebei 15
Jiaxing 15
Johannesburg 15
Turin 15
Guangzhou 14
San Francisco 14
Boston 13
Nuremberg 13
Princeton 13
Tashkent 13
Chennai 12
Hefei 12
Nashville 12
Paris 12
Rio de Janeiro 12
The Dalles 11
Curitiba 10
Denver 10
Dhaka 10
Guayaquil 10
Mexico City 10
Naples 10
Redwood City 10
Ankara 9
Baghdad 9
Brasília 9
Dublin 9
Figino 9
Ribeirão Preto 9
Biên Hòa 8
Da Nang 8
Kunming 8
Leawood 8
Poplar 8
Pune 8
Riyadh 8
Salt Lake City 8
San Mateo 8
Washington 8
Bitonto 7
Totale 7.363
Nome #
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy 228
Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration 216
Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients 211
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy 209
ABNORMAL METHYLATED DNA REGIONS INDICATE AN ATYPICAL RESPONSE OF THE CD4+ T CELLS IN IGA NEPHROPATHY PATIENTS 185
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 179
A transcriptomic study of Hereditary Angioedema attacks 177
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 173
Cultivar classification of Apulian olive oils: Use of artificial neural networks for comparing NMR, NIR and merceological data 168
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection 157
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 157
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 151
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis 147
Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases 145
Endothelial-to-Mesenchymal Transition (EndMT) in Swine Renal Ischemia Reperfusion (I/R) Injury Is Mediated by Complement and AKT Pathway 143
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 141
AQP5: Renal Aquaporins Family Got a New Member 140
A kinetic test for the assay of the C1 esterase-inhibitor 139
Role of let-7b in the regulation of N-acetylgalactosaminyltransferase 2 in IgA nephropathy 138
Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion (I/R) injury 138
MP065 ABERRANT METHYLATED DNA REGIONS LEAD TO LOW ACTIVATION OF CD4+ T CELLS WITH A CONSEQUENT IMBALANCE OF THE TH1/TH2 POLARIZATION IN IGA NEPHROPATHY PATIENTS 134
Micropatterning control of tubular commitment in human adult renal stem cells 130
Immunosuppressive agents for treating IgA nephropathy 129
Activated Factor X Induces Peripheral Blood Mononuclear Cells Activation During Hemodialysis 128
Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury 127
ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACUTE RENAL TUBULAR CELL INJURY BY MEANS OF SPECIFIC TLR2-DRIVEN PARACRINE FACTORS 127
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 126
Activation of NADPH oxidase and coagulation cascade in renal ischemia-reperfusion (I/R) 125
ISCHEMIA AND ISCHEMIA-REPERFUSION (I/R) INDUCE GLOMERULAR AND TUBULAR AKT AND NIK ACTIVATION IN HUMAN (H) AND PIG (P) KIDNEYS 122
ALTERED MONOCYTE GENE EXPRESSION AND EXPANSION OF CD14 (+) CD16 (+) CELL SUBSET IN IgA NEPHROPATHY PATIENTS 121
COVID-19 and kidney transplantation: an Italian Survey and Consensus 121
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 120
AKI and stem cells 118
ALPHA-SMOOTH MUSCLE ACTIN (ALPHA-SMA) AND PLATELET-DERIVED GROWTH-FACTOR-BETA RECEPTOR (PDGF-BETA-R) EXPRESSION IN HUMAN-IGA NEPHROPATHY (IGAN) - A TUBULOINTERSTITIAL CORRELATION 116
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: Role of NF-κB and Lyn 116
RENAL EXPRESSION OF MONOCYTE CHEMOTATIC PROTEIN-1 (MPC-1) AND EPIDERMAL GROW FACTOR (EGF) IN CHILDREN WITH OBDTRUCTIVE HYDRONEPHROSIS 114
MicroRNAs in glomerular diseases from pathophysiology to potential treatment target 114
AKT activation may represent the molecular link between rapamycin (RAPA) treatment and insulin-resistance in renal transplant recipients. 114
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy 112
A COMBINED MIRNA BIOMARKER FOR NON-INVASIVE DIAGNOSIS OF IDIOPATHIC IGA NEPHROPATHY: AN INTERNATIONAL MULTICENTRE STUDY (NIDIGAN STUDY) 111
Iga Nephropathy and urinary proteomics 111
IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection 110
A bioartificial renal tubule device embedding human renal stem/progenitor cells 110
null 108
Coagulation activation induces increased NADPH-dependent reactive oxygen species (ROS) generation in haemodialysis (HD) 108
Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation 108
Omics studies for comprehensive understanding of immunoglobulin A nephropathy: State-of-the-art and future directions 108
IDENTIFICATION OF QUANTITATIVE TRAIT LOCI FOR DEGLYCOSYLATED IGA1 SERUM LEVELS IN FAMILIAL IGA NEPHROPATHY 107
NMR-based metabolomic study of Apulian Coratina extra virgin olive oil extracted with a combined ultrasound and thermal conditioning process in an industrial setting 107
MicroRNAs in Kidney Diseases 106
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 103
Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients 102
null 101
An end stage kidney disease predictor based on an artificial neural networks ensemble 101
Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment 100
Multiple rare genetic variants co‐segregating with familial IgA nephropathy all act within a single immune‐related network 100
A proton nuclear magnetic resonance-based metabolomic approach in IgA nephropathy urinary profiles 98
MicroRNAs in kidney diseases: New promising biomarkers for diagnosis and monitoring 97
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 97
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 95
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION 95
Determination of hydroxytyrosol and tyrosol in human urine after intake of extra virgin olive oil produced with an ultrasounds-based technology 94
null 93
Low coagulation-activating dialyzer reduces progression of atherosclerosis in hemodialysis modulatig serum bone morphogenetic proteins (BMPs) 93
Is it time for personalized therapy in IgA nephropathy patients? 90
Immunosuppressive agents for treating IgA nephropathy 88
DRG's and cost/efficacy indicators in nephrology and dialysis. Results at a hospital division 87
Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients 86
RARE GENETIC VARIANTS IMPLICATED IN INNATE AND ADAPTIVE IMMUNITY CO-SEGREGATE WITH FAMILIAL IGA NEPHROPATHY 86
Altered modulation of WNT–β-catenin and PI3K/Akt pathways in IgA nephropathy 85
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells 85
From-omics to personalized medicine in nephrology: Integration is the key 84
Patient classification and outcome prediction in IgA nephropathy 84
Erratum: Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy (Nephrology Dialysis Transplantation (2009) DOI: 10.1093/ndt/gfp356) 79
Pharmacogenomics: A new paradigm to personalize treatments in nephrology patients 79
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR) 78
β3 adrenergic receptor as potential therapeutic target in ADPKD 78
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy 77
LINKAGE ANALYSIS DETECTES TWO ADDITIONAL REGIONS IN FAMILIAL IGA NEPHROPATHY 75
Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy 74
GENOME-WIDE SCAN OF COPY NUMBER VARIATIONS (CNVS) IDENTIFIES A VARIABLE REGION AT 3P21. 1 REGULATING THE TLR9 EXPRESSION IN IGA NEPHROPATHY PATIENTS 73
C5b-9 generation and cytokine production in hemodialyzed patients 71
Kidney and urine cell transcriptomics in IgA nephropathy and lupus nephritis: a narrative review 70
IgAN Genetic Risk Score in the Clinical Setting 69
null 69
null 69
Epidemiology and ancestral difference 69
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients 68
null 65
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 63
MIR-148B UPREGULATION MODULATING CORE 1, B1, 3-GALACTOSYLTRANSFERASE 1 EXPRESSION EXPLAINS THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN IGA NEPHROPATHY 63
Serum Levels of miR-148b and Let-7b at Diagnosis May Have Important Impact in the Response to Treatment and Long-Term Outcome in IgA Nephropathy 62
null 62
Searching for IgA nephropathy candidate genes: Genetic studies combined with high throughput innovative investigations 57
Genome-wide association studies in kidney diseases: Quo Vadis 57
The authors reply 55
null 52
null 52
New directions in the pathogenesis of primary erythrocytosis in IgAN 51
Biomarkers and Precision Medicine in IgA Nephropathy 51
Totale 10.782
Categoria #
all - tutte 48.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022546 0 0 8 28 22 61 14 31 44 78 90 170
2022/2023998 106 162 84 82 101 150 13 118 144 7 17 14
2023/2024365 33 47 12 34 31 115 4 20 13 10 9 37
2024/20251.673 44 46 116 56 71 116 181 156 53 90 257 487
2025/20264.125 562 163 205 417 491 244 408 112 496 415 176 436
2026/2027450 118 181 151 0 0 0 0 0 0 0 0 0
Totale 11.240